X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (457) 457
Publication (46) 46
Magazine Article (14) 14
Patent (7) 7
Book Chapter (4) 4
Conference Proceeding (4) 4
Book / eBook (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (154) 154
female (113) 113
index medicus (100) 100
male (91) 91
nutrition & dietetics (89) 89
adult (79) 79
middle aged (65) 65
aged (43) 43
animals (37) 37
oncology (37) 37
nutrition (30) 30
obesity (30) 30
metabolism (28) 28
diet (25) 25
analysis (24) 24
research (24) 24
short bowel syndrome (24) 24
parenteral nutrition (23) 23
surgery (23) 23
physiological aspects (22) 22
medicine (21) 21
anthropometry (20) 20
body composition (20) 20
body mass index (20) 20
cancer (20) 20
nutritional status (20) 20
bariatric surgery (19) 19
gene expression (19) 19
mice (19) 19
proteins (19) 19
gastroenterology and hepatology (18) 18
rats (18) 18
dietary supplements (17) 17
genetic aspects (16) 16
health aspects (16) 16
oxidative stress (16) 16
medicine, general & internal (15) 15
time factors (15) 15
young adult (15) 15
supplementation (14) 14
adolescent (13) 13
aged, 80 and over (13) 13
amino acids (13) 13
endocrinology & metabolism (13) 13
expression (13) 13
ovarian cancer (13) 13
ovarian neoplasms - genetics (13) 13
ovarian neoplasms - pathology (13) 13
disease (12) 12
genes (12) 12
kinetics (12) 12
nutrition. foods and food supply (12) 12
treatment outcome (12) 12
women (12) 12
zinc (12) 12
apoptosis (11) 11
brazil (11) 11
deficiency (11) 11
energy intake (11) 11
gene expression profiling (11) 11
inflammation (11) 11
malnutrition (11) 11
patients (11) 11
prospective studies (11) 11
protein (11) 11
weight loss (11) 11
absorption (10) 10
biology (10) 10
care and treatment (10) 10
case-control studies (10) 10
children (10) 10
composição corporal (10) 10
further section (10) 10
iron (10) 10
management (10) 10
research article (10) 10
risk factors (10) 10
studies (10) 10
tumors (10) 10
weight-loss (10) 10
bioavailability (9) 9
biomarkers - blood (9) 9
cells (9) 9
cross-sectional studies (9) 9
follow-up studies (9) 9
gene-expression (9) 9
growth (9) 9
nitrogen (9) 9
obesity - metabolism (9) 9
rats, wistar (9) 9
retrospective studies (9) 9
weight control (9) 9
adults (8) 8
body-composition (8) 8
chemotherapy (8) 8
child (8) 8
diagnosis (8) 8
dna (8) 8
gastric bypass (8) 8
gastrointestinal surgery (8) 8
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (384) 384
Portuguese (84) 84
Spanish (13) 13
Italian (5) 5
French (2) 2
Chinese (1) 1
German (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e41439
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2017, Volume 17, Issue 1, pp. 366 - 11
Journal Article
Nature Communications, ISSN 2041-1723, 01/2014, Volume 5, Issue 1, p. 2977
Journal Article
Journal of Experimental and Clinical Cancer Research, ISSN 1756-9966, 05/2017, Volume 36, Issue 1, pp. 63 - 18
Background: Epithelial ovarian cancer (EOC) is a spectrum of different diseases, which makes their treatment a challenge. Forkhead box M1 (FOXM1) is an... 
Immunohistochemistry | Anticancer drug | Cell line | Prognosis | Epithelial ovarian cancer | Chemoresistance | FOXM1 | Microarray | Subtype | APOPTOSIS | PROLIFERATION | BRCA1 | CELL CARCINOMA | CISPLATIN SENSITIVITY | OVEREXPRESSION | OLAPARIB | INVASION | ONCOLOGY | POOR-PROGNOSIS | GENE-EXPRESSION | RNA, Small Interfering - genetics | Cell Proliferation | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Gene Expression Profiling | Cystadenocarcinoma, Serous - genetics | Ovarian Neoplasms - mortality | Biomarkers, Tumor | Gene Knockdown Techniques | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Neoplasm Metastasis | Neoplasm Grading | Neoplasms, Glandular and Epithelial - mortality | Cell Transformation, Neoplastic - genetics | Aged, 80 and over | Adult | Female | Ovarian Neoplasms - drug therapy | Neoplasms, Glandular and Epithelial - pathology | Kaplan-Meier Estimate | Disease Progression | Drug Resistance, Neoplasm - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | DNA Repair | Protein Isoforms | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Cell Line, Tumor | Forkhead Box Protein M1 - genetics | Aged | Neoplasm Staging | Cell Movement | Chemotherapy | Patient outcomes | Physiological aspects | Genetic aspects | Research | Gene expression | Drug therapy | Oncogenes | Ovarian cancer | Cancer | Signal transduction | Transcription factors | Medical prognosis | Surgery | Rodents | Mutation | Drug resistance | Cancer therapies | DNA repair | Deoxyribonucleic acid--DNA
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 4, pp. 1113 - 1119
Purpose MicroRNAs (miRNAs) are small, noncoding RNA molecules that can be down- or upregulated in colorectal cancer and have been associated to prognosis and... 
Radiology | Hematology, Oncology and Palliative Medicine | miRNA | Predictive factors | Rectal cancer | Preoperative chemoradiotherapy | CAPECITABINE | ONCOLOGY | COLORECTAL-CANCER | MICRORNAS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Capecitabine | Rectum - pathology | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Organoplatinum Compounds - administration & dosage | RNA, Neoplasm - analysis | Fluorouracil - administration & dosage | Rectal Neoplasms - genetics | MicroRNAs - analysis | Reverse Transcriptase Polymerase Chain Reaction - methods | Sensitivity and Specificity | Adult | Female | Rectal Neoplasms - pathology | Microarray Analysis - methods | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Rectal Neoplasms - therapy | Chemoradiotherapy, Adjuvant - methods | Biopsy | Neoadjuvant Therapy - methods | Rectum - chemistry | Aged | Deoxycytidine - analogs & derivatives | Care and treatment | MicroRNA | RNA | Oncology, Experimental | Colorectal cancer | Antisense RNA | Research | Cancer | Polymerase chain reaction | DNA microarrays | Prognosis | Surgery | Rectum | Reverse transcription | Radiotherapy | Tumors | SURGERY | PATIENTS | NEOPLASMS | SPECIFICITY | RECTUM | BIOPSY | TRANSCRIPTION | SENSITIVITY | POLYMERASE CHAIN REACTION | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY
Journal Article
Nutrition, ISSN 0899-9007, 2016, Volume 32, Issue 1, pp. 83 - 87
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2015, Volume 136, Issue 3, pp. 721 - 729
Journal Article
British Journal of Cancer, ISSN 0007-0920, 08/2017, Volume 117, Issue 5, pp. 628 - 638
Background: Lurbinectedin is a novel anticancer agent currently undergoing late-stage (Phase II /III) clinical evaluation in platinum-resistant ovarian,... 
tumour-associated macrophages | MONOCYTES | DEPLETION | ANTITUMOR | OVARIAN-CARCINOMA | tumour immunology | RESPONSES | ONCOLOGY | inflammation | TRABECTEDIN | THERAPIES | novel drug | PM01183 | POLARIZATION | PROGRESSION | Vascular Endothelial Growth Factor A - biosynthesis | Gene Expression - drug effects | Apoptosis - drug effects | Humans | Caspase 8 - metabolism | Antineoplastic Agents, Alkylating - pharmacology | Fibrosarcoma - immunology | Monocytes - metabolism | Gene Expression Profiling | Macrophages | Trabectedin | Heterocyclic Compounds, 4 or More Rings - pharmacology | Heterocyclic Compounds, 4 or More Rings - therapeutic use | U937 Cells | Dioxoles - pharmacology | Female | Neovascularization, Pathologic - prevention & control | Leukocyte Count | Monocytes - physiology | Carbolines - therapeutic use | Ovarian Neoplasms - drug therapy | Tumor Microenvironment - drug effects | Tetrahydroisoquinolines - pharmacology | Interleukin-8 - biosynthesis | rho GTP-Binding Proteins - genetics | Down-Regulation | Mice, Inbred C57BL | Cell Adhesion - drug effects | Antineoplastic Agents, Alkylating - therapeutic use | Monocytes - drug effects | Tumor Microenvironment - immunology | Xenograft Model Antitumor Assays | Cell Movement - drug effects | Animals | Chemokine CCL2 - biosynthesis | HL-60 Cells | Mice | Fibrosarcoma - drug therapy | Carbolines - pharmacology | Animal models | Transcription | Leukocyte migration | Lung cancer | Leukocytes (mononuclear) | Guanine nucleotide-binding protein | Tissues | DNA repair | Anticancer properties | Phagocytes | Adhesive strength | Platinum | Inhibition | Vascular endothelial growth factor | Growth factors | Deoxyribonucleic acid--DNA | Myeloid cells | BRCA1 protein | Small cell lung carcinoma | Vessels | Caspase | Breast cancer | Inflammation | Caspase-8 | Monocytes | Breast | Viability | In vitro methods and tests | Monocyte chemoattractant protein 1 | Cancer | Guanosinetriphosphatase | Tumors | Apoptosis | Translational Therapeutics
Journal Article
Human Pathology, ISSN 0046-8177, 11/2018, Volume 81, pp. 235 - 244
About one-third of endometrial carcinomas (ECs), mainly of endometrioid histology, harbor the mismatch repair (MMR) defects and microsatellite instability... 
MLH1 silencing | MMR defect | Endometrial cancer | Targeted sequencing | ARID1A | Lynch syndrome | ARID 1A | MLH 1 silencing | MUTATIONS | PATHOLOGY | CANCER | EXPRESSION | DEFICIENCY | Genetic research | Genetic aspects | Gene mutations | Analysis | Genes | Cancer | Polymerase chain reaction | DNA methylation | Genomes | Mutation | Deoxyribonucleic acid--DNA | Tumors
Journal Article